Wavelength Pharmaceuticals

1 stories about Wavelength Pharmaceuticals
default image

Perrigo Completes Sale of Israel Business for $110 million

23.11.17|Lilach Baumer
The buyer, New York-based investment firm SK Capital, has $1.9 billion assets under management